Urgent Call for Universal Diabetes Care in Europe Amidst Political Apathy

By João L. Carapinha

November 25, 2024

The article from Euractiv titled “Universal access to diabetes care urgently needed in Europe, but political will is lacking” highlights several critical issues and recommendations regarding diabetes care in Europe. The growing challenge of diabetes across the continent highlights the urgent need for universal access to diabetes care. With 32 million people living with diabetes, one-third of whom remain undiagnosed, the situation demands immediate attention and action.

Current State of Diabetes Care in Europe

The article emphasizes that diabetes is a significant and growing health challenge in Europe, affecting millions and indicating a pressing need for universal access to diabetes care.

Lack of Political Will

Despite the severity of the issue, there is a lack of sufficient political will to address diabetes comprehensively. While there is growing awareness and enthusiasm from MEPs, more must be done to ensure that diabetes receives the prioritization it needs within the European health agenda.

Key Objectives of IDF Europe

The International Diabetes Federation (IDF) Europe has three main priorities:

– Keeping the person living with diabetes at the center of all efforts.
– Advocacy to increase awareness and push for stronger prioritization of diabetes within the EU’s health agenda.
– Ensuring universal access to diabetes care, including advanced treatments like continuous glucose monitoring (CGM).

Advocacy and Partnerships

IDF Europe is working in partnership with organizations like the World Health Organization (WHO) Europe to amplify their collective voice and achieve impactful outcomes. Their aim is to unite various groups and build advocates within health systems to ensure universal access to diabetes care for all individuals.

Financial and Resource Challenges

The financial burden of diabetes on health systems is substantial. A significant portion of healthcare budgets are allocated to medications and managing complications. Also, the socio-economic impact, including loss of productivity, is significant.

Calls to Action

IDF Europe is calling for politicians to invest in prevention and early treatment to avert costly and devastating complications. Achieving universal access to diabetes care requires not just financial resources but also a committed effort to place diabetes at the forefront of the European agenda.

Need for Comprehensive Plans

There is a pressing need for a structured plan to turn promises into tangible actions. While resolutions and declarations have been made, a comprehensive approach is necessary to ensure targets for diabetes care are met in the medium to long term.

Healthcare System Improvements

Improving access to healthcare services, medicines, and technologies is crucial. This includes strengthening primary care systems, allocating resources more efficiently, and ensuring uninterrupted and affordable access to necessary treatments and tools.

In summary, the article emphasises the urgent need for universal access to diabetes care in Europe. It identifies gaps in the current healthcare systems, and emphasizes the necessity for strong political will. It also notes that comprehensive plans are needed to effectively tackle the escalating diabetes crisis. Universal access to diabetes care is essential for improving health outcomes across Europe.

Reference url

Recent Posts

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.